Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Comparison between the areas of scarred and active toxoplasmic retinochoroiditis
by
Duraffour Pierre
, Brézin, Antoine P
, Touboul Arnaud
, Hoogewoud Florence
, Mehanna Chadi
, Monnet Dominique
in
Infections
/ Lesions
/ Localization
/ Ophthalmology
/ Patients
/ Retinochoroiditis
/ Serology
/ Toxoplasmosis
/ Variables
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Comparison between the areas of scarred and active toxoplasmic retinochoroiditis
by
Duraffour Pierre
, Brézin, Antoine P
, Touboul Arnaud
, Hoogewoud Florence
, Mehanna Chadi
, Monnet Dominique
in
Infections
/ Lesions
/ Localization
/ Ophthalmology
/ Patients
/ Retinochoroiditis
/ Serology
/ Toxoplasmosis
/ Variables
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Comparison between the areas of scarred and active toxoplasmic retinochoroiditis
by
Duraffour Pierre
, Brézin, Antoine P
, Touboul Arnaud
, Hoogewoud Florence
, Mehanna Chadi
, Monnet Dominique
in
Infections
/ Lesions
/ Localization
/ Ophthalmology
/ Patients
/ Retinochoroiditis
/ Serology
/ Toxoplasmosis
/ Variables
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Comparison between the areas of scarred and active toxoplasmic retinochoroiditis
Journal Article
Comparison between the areas of scarred and active toxoplasmic retinochoroiditis
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Background/objectivesTo assess the ratio of scarred/active areas of fundus lesions in patients with presumed ocular toxoplasmosis.Subjects/methodsRetrospective monocentric study of patients with presumed ocular toxoplasmosis seen between May 2004 and February 2018. Patients with a positive anti-Toxoplasma serology presenting characteristic fundus lesions. Cases with images of both baseline active and scarred lesions of the fundus were included. The borders of each active or scarred lesion were delineated on colour photographs by two independent observers and the area of the lesions was calculated using Digimizer 4.2.2 (MedCalc Software, Ostend, Belgium). The interobserver variability of the measures was recorded and their means were used for further calculations. To study the ratio of the area of scarred retinochoroiditis over the area of the baseline active lesion (R).ResultsA total of 171 cases (83 males, 88 females) with a mean age of 31.6 ± 13.8 years were included. The average areas of active and scarred retinochoroiditis were, respectively, 1.32 ± 1.59 and 1.79 ± 2.36 optic disc area. The average ratio between scarred and active areas of retinochoroiditis was 1.36 [range 0.54–2.18]. The administration of a systemic treatment [R = 1.25, p = 0.003], the absence of a pre-existing scar [R = 1.05, p < 0.001] and a peripapillary location of the lesion [R = 0.85, p < 0.001] were each significantly associated with smaller scarred/active area ratios.ConclusionsWe assessed in a standardized manner the ratio of scarred/active areas of toxoplasmic lesions and showed that the area of scarred lesions was on average slightly larger than the area of active retinochoroiditis.
Publisher
Nature Publishing Group
Subject
This website uses cookies to ensure you get the best experience on our website.